Eli Lilly (LLY) FY2013 results: revenue $23.1 billion, up 2.3% on the year
Eli Lilly & Co. (LLY) reported revenue of $23.1 billion for fiscal 2013, the year ended 31 December 2013, up 2.3% on the year before. Net income was $4.7 billion, up 14.6%, and diluted earnings per share $4.32. The figures are the company's own, from the 10-K it filed with the SEC on 19 February 2014.
Revenue
$23.1 billion
+2.3% on the year
FY2007FY2013
Operating margin
n/a
FY2007FY2013
Net income
$4.7 billion
+14.6% on the year
FY2007FY2013
Diluted EPS
$4.32
+18.0% on the year
FY2007FY2013
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Revenue
23,113
22,603
24,286
+2.3%
Cost of revenue
4,908
4,796
5,068
+2.3%
Gross profit
18,205
17,807
19,219
+2.2%
Gross margin
78.8%
78.8%
79.1%
Research and development
5,531
5,278
5,021
+4.8%
Selling, general and administrative
7,126
7,514
7,880
-5.2%
Interest expense
160
178
186
-10.0%
Pre-tax income
5,889
4,902
6,139
+20.2%
Income tax
1,204
1,320
1,002
-8.7%
Effective tax rate
20.5%
26.9%
16.3%
Net income
4,685
4,089
4,348
+14.6%
Net margin
20.3%
18.1%
17.9%
Diluted EPS
$4.32
$3.66
$3.90
+18.0%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Operating cash flow
5,735
5,305
7,234
+8.1%
Capital expenditure
1,012
905
672
+11.8%
Free cash flow
4,723
4,399
6,562
+7.4%
Free cash flow margin
20.4%
19.5%
27.0%
Cash from investing
-2,073
-2,833
-4,824
Cash from financing
-3,829
-4,420
-2,370
Depreciation and amortisation
1,446
1,462
1,374
-1.1%
Share-based compensation
145
142
147
+2.4%
Buybacks
1,698
721
0.0
+135.5%
Dividends paid
2,121
2,187
2,180
-3.0%
Dividend per share
n/a
n/a
$1.96
Diluted shares, weighted
1,085m
1,117m
1,114m
-2.9%
Balance sheet
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Shareholders' equity
17,631
14,765
13,542
+19.4%
Non-controlling interest
9.3
8.7
-6.1
+6.9%
Short-term borrowings
n/a
11.9
1,522
Debt
5,213
5,531
6,982
-5.8%
Other liabilities
12,395
14,082
11,620
-12.0%
Total liabilities and equity
35,249
34,399
33,660
+2.5%
Fixed assets
7,976
7,760
7,760
+2.8%
Goodwill
1,517
1,501
1,435
+1.0%
Intangible assets
2,814
3,186
n/a
-11.7%
Investments
9,192
7,979
5,004
+15.2%
Cash and equivalents
3,830
4,019
5,922
-4.7%
Receivables
3,434
3,336
3,598
+2.9%
Inventory
2,929
2,644
2,300
+10.8%
Other assets
3,557
3,973
7,640
-10.5%
Total assets
35,249
34,399
33,660
+2.5%
10-K for the year ended 31 December 2013, filed 19 February 2014: the filing.